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Despite commercial interest and ethnobotanical data, the pharmacological activities of a number of indigenous Pelargonium species hitherto
remain poorly explored. The acetone extracts of twenty-one Pelargonium species (section Pelargonium) were included in this study. Using
the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, potent anti-oxidant activity was observed for the crude extracts of P. betulinum and P. crispum
(IC50 values of 4.13±0.14 μg/ml and 4.49±0.18 μg/ml, respectively compared to ascorbic acid, IC50=4.72±0.14 μg/ml). The antimicrobial (both
bacterial and fungal) potential of the extracts was evaluated by using the minimum inhibitory assay. The crude extracts of P. glutinosum (SBG),
P. pseudoglutinosum, P. scabrum and P. sublignosum exhibited considerable antimicrobial activity against the Gram-positive test bacteria, with
P. pseudoglutinosum demonstrating the highest inhibitory activity (MIC=39 μg/ml); however the aforementioned species were also relatively
cytotoxic. The 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) cellular viability assay was used to determine the toxicity of
the acetone extracts against transformed human kidney epithelial (Graham) cells. The acetone extracts of P. sublignosum and P. citronellum
(NBG) displayed the highest toxicities (IC50=11.89±1.54 μg/ml and 19.14±0.98 μg/ml, respectively). The results from the toxicity assay
suggested that the antimicrobial activity of the extracts may be ascribed to general cytotoxic effects. Considering all the results collectively,
Pelargonium cordifolium appears to be the most promising species requiring further investigation.
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Of the over 250 Pelargonium species (Geraniaceae), approx-
imately 80% occur in South Africa with the highest concentration
of species growing in the winter rainfall region of the south-
western Cape (Van der Walt and Vorster, 1988; Lis-Balchin,
1996). The common name geranium has been erroneously used to
refer to a plant that should correctly be called a pelargonium
(Van der Walt, 1977). The Pelargonium species are divided into
16 recognised sections (Bakker et al., 2004) that are phylogenet-
ically arranged. Van der Walt (1985) taxonomically revised
the section Pelargonium, which contains a total of twenty-four
species. Many of the species are aromatic and in particular,
P. capitatum, P. graveolens and P. radens are used in cultivation
programmes for the ennoblement of ‘geranium’ oil. Studies on⁎ Corresponding author.
E-mail address: viljoenam@tut.ac.za (A.M. Viljoen).
0254-6299/$ - see front matter © 2007 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2007.08.011Pelargonium have intensively focused on the chemical compo-
sition of the essential oils (Williams and Harborne, 2002).
In South Africa, many scented and unscented Pelargonium
species are used as traditional remedies by the Sotho, Xhosa,
Khoi-San and Zulus (Watt and Breyer-Brandwijk, 1962) for
wounds, abscesses, fever, colic, nephritis and suppression of
urine, colds and sore throats, haemorrhoids, gonorrhoea, and are
also used for stimulating milk-production, for anti-helminthic
infections and as an insecticide (Lis-Balchin, 1996).
Pelargoniums were also used in the past to provide relief in
cases of diarrhoea and dysentery; this suggested a potential
antispasmodic mechanism of action on smooth muscle (Lis-
Balchin, 1996) which was experimentally verified in some of the
fractions of the many different scented and unscented species
studied (Lis-Balchin et al., 1996). The profound antimicrobial
activity of Pelargoniumsmay partly explain their wound-healing
properties (Lis-Balchin, 1996). Previous reports have documen-
ted the antimicrobial activity of the extracts of Pelargoniums andts reserved.
154 J.Y.Y. Lalli et al. / South African Journal of Botany 74 (2008) 153–157their constituents against several bacterial pathogens such as
Staphylococcus aureus, S. pneumoniae, Escherichia coli,
Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeru-
ginosa and Haemophilus influenzae (Mativandlela et al., 2006).
The methanolic extracts of representative species and cultivars
of Pelargonium (Geraniaceae) were found to exert pronounced
antibacterial and anti-oxidant activities (Lis-Balchin and Deans,
1996). A study carried out by Lis-Balchin et al. (1998) showed
that the methanolic and petroleum spirit extracts of a number of
Pelargonium species and cultivars have substantial antibacterial
activity. The latter two studies suggest that Pelargonium extracts
can potentially be used as novel anti-oxidant and antibacterial
agents in the food and cosmetic industries.
Regardless of the proclaimed uses of various Pelargonium
species, there has been very little commercial exploitation.
Pelargonium reniforme and the closely related P. sidoides
are used as ingredients in a German remedy marketed as
“Umckaloabo”, which is used to treat bronchitis in children. The
presence of umckalin and structurally related coumarins may be
partly responsible for the activity of the medicine prepared from
P. reniforme (Van Wyk et al., 2002).
The utilisation of natural products in all industrial sectors is
increasing and studies of the various biotherapeutic properties
of the extracts of several unexplored Pelargoniums will better
equip us to further develop the therapeutic application and
commercialisation of Pelargonium species. To provide
scientific evidence for their reported uses, the aims of the
present study were to investigate the in vitro antimicrobial and
anti-oxidant properties as well as the in vitro toxicity of the
acetone extracts of selected Pelargonium species (section
Pelargonium).
2. Materials and methods
2.1. Collection of plant material
The aerial parts (stems, stalks and leaves) of 21 Pelargonium
species were harvested from the National Botanical Garden
(NBG), Stellenbosch Botanical Garden (SBG) and the Walter
Sisulu Botanical Garden (WSBG). Voucher specimens of all
the material collected were deposited in the herbarium of the
Department of Pharmacy and Pharmacology, University of the
Witwatersrand, Johannesburg.
2.2. Preparation of plant extracts
Plant material was dried at 30 °C. The dried, ground material
was extracted at 40 °C for 3 h in acetone. The extracts
were filtered through Whatman® No. 41 filter paper (pore size
20–25 μm) and dried under vacuum using a rotary evaporator.
The extracts were further reduced in the fumehood and once
concentrated to dryness were kept at 4 °C until required.
2.3. Anti-oxidant activity assay
The radical scavenging activities of the acetone extracts were
determined using a modified version of the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method (Mambro et al., 2003). Briefly,
the stable DPPH radical has strong absorption at 550 nm,
but upon reduction by an anti-oxidant or radical species bleach-
ing of the purple coloured DPPH occurs, with a decrease in
absorption at 550 nm.
Fifty microlitres of extract (100 μg/ml) dissolved in dimethyl
sulfoxide (DMSO; Saarchem) and 200 μl DPPH (Fluka)
dissolved in analytical grade methanol (Ultrafine Limited) to
yield a concentration of 96 μM constituted the reaction mixture,
which was added to alternating columns of the plate with the
reaction mixtures for negative controls containing extracts and
methanol. Analytical grade ascorbic acid was used as a positive
control. The plates were shaken for 2 min using an automated
microtitre plate reader (Labysystems Multiskan RC). After
allowing the plates to stand for 30 min at room temperature
in the dark, the absorbance at 550 nm was measured using
an UV/VIS spectrophotometer linked to a computer equipped
with GENESIS® software. The percentage decolourisation as a
measure of the free radical scavenging activity of the sample
was calculated using the following equation:
% Decolourisation = ([Av controls− (Av sampleDPPH −
Av samplemethanol)]×100)/Av controls. Where:−Av controls=aver-
age absorbance of all DPPH control wells−average absorbance of
all methanol control wells; Av sampleDPPH=average absorbance of
sample wells with DPPH and Av samplemethanol=average absor-
bance of sample wells with methanol.
The IC50 values (concentration of extract producing 50%
decolourisation) were determined using Enzfitter® version 1.05
software. Each experiment was carried out in triplicate.
2.4. Minimum inhibitory concentration (MIC) assay
The antimicrobial activity of each non-volatile extract
was evaluated using the microtitre plate dilution method
(Eloff, 1998). The minimum inhibitory concentration values
were determined against four micro-organism strains which
included two Gram-positive bacteria S. aureus (ATCC 12600)
and Bacillus cereus (ATCC 11778), one Gram-negative bac-
terium K. pneumoniae (NCTC 1633) and one fungal strain
Candida albicans (ATCC 10231). The reference stock cultures
were obtained from the National Health Laboratory Services
(NHLS), Johannesburg and were maintained in the Depart-
ment of Pharmacy and Pharmacology, University of the
Witwatersrand.
Stock solutions of the plant extracts were prepared in acetone
which did not inhibit the bacterial or fungal growth at the
concentrations tested. Serial 1:1 dilutions of the plant extracts
(100 μl) were prepared in sterile water (100 μl) before culture
(100 μl) containing a final density of 1×106 CFU's/ml was
added to each well. For the observation of normal bacterial and
fungal growth, extract-free solutions were included as blank
controls. The antimicrobial agents, ciprofloxacin (Oxoid) or
amphotericin B (Oxoid), were used as positive controls for
bacteria and fungi, respectively. The plates were incubated
under normal atmospheric conditions, at 37 °C for 24 h
(bacteria) and 48 h (yeast). After the incubation period,
131.8 μM p-iodo-nitrotetrazolium violet (INT; Sigma) solution
Table 1













K. p. NCTC 1633 B. c. ATCC 11778 S. a. ATCC 12600 C. a. ATCC 10231
P. betulinum NBG (AV 941) 4.13±0.14 1000 330 1130 2000 88.55±1.51
P. capitatum Strand (AV 918) Nd 1000 1000 2000 1500 101.59±1.75
P. citronellum NBG (AV 943) 23.70±3.68 3000 250 160 1000 19.14±0.98
P. citronellum SBG (AV 1172) 84.01±16.08 3000 410 160 500 59.94±2.33
P. cordifolium NBG (AV 1173) 5.01±0.55 1500 250 750 750 74.70±2.17
P. crispum NBG (AV 1175) 4.49±0.18 2000 380 560 1330 74.02±2.30
P. cucullatum SBG (AV 1176) 40.18±5.65 1500 250 1000 1000 73.81±2.62
P. cucullatum WSBG (AV 1177) 10.91±0.54 3330 500 2000 2000 118.89±5.32
P. glutinosum SBG (AV 939) 16.41±0.33 2000 78 78 1000 31.44±1.27
P. glutinosum WSBG (AV 1178) 29.17±0.78 2000 250 500 2000 46.29±0.81
P. graveolens SBG (AV 947) 14.49±0.46 2000 2000 4000 3330 83.31±2.56
P. greytonense SBG (AV 920) Nd 3200 250 500 1500 39.65±1.18
P. hermanniifolium SBG (AV 1181) 13.50±0.73 1500 3000 1500 1500 46.47±1.38
P. hispidum SBG (AV 946) 12.78±0.45 2000 4000 4000 3000 84.30±1.16
P. panduriforme SBG (AV 949) Nd 2000 2000 2000 2000 32.93±3.75
P. panduriforme WSBG (AV 926) 91.58±4.45 2000 500 500 1000 42.65±0.90
P. papilionaceum NBG (AV 944) 81.24±13.44 4000 8000 2000 1190 53.76±1.60
P. pseudoglutinosum NBG (AV 1182) 52.38±0.67 2000 39 39 540 30.54±5.46
P. quercifolium SBG (AV 940) 17.15±0.58 8000 330 160 2000 85.61±1.93
P. quercifolium WSBG (AV 921) 61.87±3.19 2000 1000 1000 1000 48.69±1.04
P. radens SBG (AV 942) Nd 2500 500 2000 2000 30.81±1.23
P. scabroide SBG (AV 1183) Nd 2000 250 1000 1000 53.76±1.57
P. scabrum SBG (AV 948) 7.15±0.11 2000 59 78 380 37.78±1.72
P. sublignosum SBG (AV 1184) 17.61±3.18 2000 130 78 500 11.89±1.54
P. tomentosum SBG (AV 950) 28.16±2.65 2000 2000 2000 2330 195.13±7.90
P. vitifolium SBG (AV 945) Nd 4000 1000 2000 2000 178.48±5.44
Controls – 4.72±0.14 2.5 (a) 0.31 (a) 2.5 (a) 1.25 (b) 125.56±5.04 (c)
Abbreviations: NBG=National Botanical Garden (Kirstenbosch), SBG=Stellenbosch Botanical Garden, WSBG=Walter Sisulu Botanical Garden (Johannesburg);
K.p.=K. pneumoniae, B.c.=B. cereus, S.a. =S. aureus, C.a.=C. albicans; Microbial strains: ATCC=American Type Culture Collection, NCTC=National
Collection of Type Cultures; Nd=not determined due to insufficient extract for testing; (a): ciprofloxacin, (b): amphotericin B, (c) quinine; IC50 values for anti-
oxidant activity and toxicity are mean±standard deviation (n=3); minimum inhibitory concentration (MIC) determination experiments for the antimicrobial activity
were carried out in trplicate (n=3).
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24 h (yeast). Thereafter, the plates were visually assessed
for colour change, since metabolically active micro-organisms
reduce the colourless tetrazolium salt to an intensely red-
coloured formazan salt. Minimum inhibitory concentration val-
ues were recorded as the lowest concentration resulting in
complete inhibition of micro-organism growth (the first clear
well). The MIC results were recorded in triplicate.
2.5. Toxicity assay
The toxicity profiles of the extracts were assessed using the
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) microculture tetrazolium viability assay as described
by Mosmann (1983). Transformed human kidney epithelial
(Graham) cells were maintained continuously in culture at
37 °C in 5% CO2. The trypsinised cell suspension (0.25 million
cells/ml) was plated out into 96-well microtitre plates and
incubated under humidified conditions at 37 °C in 5% CO2 for
6 h to allow the cells to adhere to the bottom of the wells (Van
Zyl and Viljoen, 2002). Thereafter, the various concentrations
of plant samples were plated out in triplicate. Each plate
included untreated cell controls and a blank cell-free control.Quinine was used as the positive control. After 44 h of
incubation, MTT (12 mM) was added to each well and the
plates incubated for a further 4 h. Thereafter, DMSO was added
to each well to stop the reaction and to solubilise the formazan
crystals. The absorbance was read at a test wavelength of
540 nm and a reference wavelength of 690 nm using a microtitre
plate reader (Labsystems iEMS Reader MF) connected to a
computer equipped with Ascent® software. The percentage
cellular viability was calculated with the appropriate controls
taken into account. The concentration which inhibited 50% of
cellular growth (IC50 value) was determined from the log
sigmoid dose–response curves generated by the Enzfitter®
software. Experiments for each extract were carried out in
triplicate.
3. Results and discussion
3.1. Anti-oxidant activity
Pelargonium betulinum (IC50=4.13±0.14 μg/ml) and
P. crispum (IC50=4.49±0.18 μg/ml) displayed greater anti-
oxidant activity than the positive control ascorbic acid (IC50=
4.72±0.14 μg/ml). Other species which showed potent radical
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(Table 1). These results are in accordance with a study con-
ducted by Lis-Balchin and Deans (1996), where pronounced
anti-oxidant activity was displayed by a number of methanolic
extracts of representative species and cultivars of Pelargonium.
Marked differences were noted in the anti-oxidant activities
of the duplicate samples of P. citronellum, P. cucullatum and
P. quercifolium.
Latté and Kolodziej (2004) established that the flavonoids
and hydrolyzable tannins isolated from P. reniforme produced
higher anti-oxidant activity than ascorbic acid. The flavonoid
derivatives detected in the tested Pelargonium extracts (Lalli,
2006) may contribute to their observed in vitro anti-oxidant
activities.
The Pelargonium species, in particular P. betulinum,
P. crispum and P. cordifolium are possible sources of anti-
oxidant compounds since these extracts were relatively non-
toxic (Table 1). These observations prompt the necessity for
further studies of the abovementioned species, focusing on
the isolation and structure elucidation of their anti-oxidant
compound/s, since they have potential use as therapeutic agents
in managing diseases associated with free radicals and also have
the potential to be employed as additives in the food or cosmetic
industries.
3.2. Antimicrobial activity
Overall, the extracts showed very promising antimicrobial
activity (Table 1). The extracts were more selective for the
Gram-positive test pathogens (in particular, B. cereus) than
for the Gram-negative bacterium which is in accordance with
studies reporting that Gram-positive bacteria are generally
more sensitive than Gram-negative bacteria to solvent extracts
(Cosentino et al., 1999; Karaman et al., 2003).
The P. pseudoglutinosum extract exerted the greatest antimi-
crobial activity against B. cereus and S. aureus (MIC=39 μg/ml).
The acetone extracts of P. glutinosum (SBG), P. scabrum and
P. sublignosum also produced considerable antimicrobial activity
against the Gram-positive bacteria. Candida albicans was found
to be least resistant to P. scabrum (MIC=380 μg/ml) which was
the second most active extract against B. cereus (MIC=59 μg/
ml). Other extracts with substantial activity against C. albicans
include P. citronellum (SBG), P. pseudoglutinosum and
P. sublignosum; while the extracts of P. betulinum and
P. capitatum were most active against K. pneumoniae
(MIC=1000 μg/ml). These favourable antibacterial and antifun-
gal activities have been reported for species belonging to
Geraniaceae (Lis-Balchin, 1990). The Pelargonium species tested
by Lis-Balchin and Deans (1996) showed pronounced antibac-
terial activity, but weak antifungal activity. However, P. capitatum
and P. cucullatum in particular showed no activity against
K. pneumoniae and S. aureus, respectively. In the study con-
ducted by Lis-Balchin and Deans (1996) the hydrophilic
(methanolic) fractions were tested, whereas in this study the
acetone extracts were tested.
When comparing the antimicrobial activities of the duplicate
samples it was noted that P. cucullatum (SBG) is more activethan P. cucullatum (WSBG). Similarly, P. glutinosum (SBG)
exerted greater antimicrobial activity than P. glutinosum
(WSBG). Distinct differences in activity against S. aureus
were observed for the duplicate samples of P. glutinosum
and P. quercifolium. In addition, the duplicate samples of
P. quercifolium displayed prominent variation in activity against
K. pneumoniae.
The extracts of P. glutinosum (SBG), P. pseudoglutinosum,
P. scabrum and P. sublignosum displayed the greatest activity
against S. aureus which is one of the most persistent infectious
micro-organisms and has been associated with primary skin
infections and is commonly found in nosocomial infections
(Steenkamp et al., 2004). An infection can hamper the process
of healing (Priya et al., 2002) thus topical antimicrobial therapy
should form an important part of wound management. The
extracts of the abovementioned species may be potential
sources of topical antimicrobial agents for the treatment of
wound infections and may be sources of effective agents for
nosocomial infections. The traditional use of Pelargoniums to
treat various ailments, such as wounds, abscesses, colds, sore
throats, diarrhoea, dysentery and gonorrhoea may be related to
their antimicrobial properties as illustrated for K. pneumoniae
and S. aureus.
3.3. Toxicity
The acetone extracts of P. sublignosum and P. citronellum
(NBG) displayed the highest toxicities (IC50=11.89±1.54 μg/ml
and IC50=19.14±0.98 μg/ml, respectively). Species exhibiting
very low toxic profiles included P. capitatum and P. cucullatum
(WSBG). Pelargonium tomentosum and P. vitifolium were not
only non-toxic, but showed promising antimicrobial activities
(Table 1). Pelargonium tomentosum also displayed considerable
anti-oxidant activity. The extracts of P. glutinosum (SBG),
P. pseudoglutinosum, P. scabrum and P. sublignosum exhibited
considerable antimicrobial activity against the test Gram-
positive bacteria and also produced relatively high levels of
cytotoxicity.
The results from the MTT assay suggest that the antimicro-
bial action of the extracts may be ascribed to general cytotoxic
effects. Extracts from plant material of the same species
collected from different localities that showed reasonably
similar toxicity profiles include the P. glutinosum and
P. panduriforme samples (Table 1). The other three duplicate
samples showed considerable differences in their toxicity
profiles. It is well-known that the toxicity can vary considerably
for members of the same species of a plant growing in different
areas; since the geographical variation influences the compo-
sition and ratio of constituents (Steyn, 1934). Variations in
growing conditions such as solar radiation and water content
can contribute to the synthesis of different related compounds in
aromatic plants (Nuńez and De Castro, 1992).
The in vitro pharmacological properties displayed by the
extracts in this study substantiate their use in traditional
medicines and furthermore, promote their potential commercial
utilisation within the realm of the food, cosmetic and phar-
maceutical industries; however, their toxicity profiles must be
157J.Y.Y. Lalli et al. / South African Journal of Botany 74 (2008) 153–157considered. In particular, P. betulinum, P. cordifolium, P. crispum,
P. hispidum, P. quercifolium (SBG) and P. tomentosum have a
potential niche in therapeutics due to their promising in vitro
biological activities and their low toxicity profiles. Further
studies involving biological systems are necessary to provide
a rational basis for validation of their potential therapeutic
applications.
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